Literature DB >> 11401892

Eotaxin expression after segmental allergen challenge in subjects with atopic asthma.

C M Lilly1, H Nakamura, O I Belostotsky, K J Haley, E A Garcia-Zepeda, A D Luster, E Israel.   

Abstract

Expression of pulmonary eotaxin protein and mRNA was determined in six subjects with atopic asthma and five nonatopic normal subjects. Levels of eotaxin expression and eosinophil mobilization were compared before and after segmental allergen challenge in subjects with atopic asthma. In the absence of allergen challenge, we found significantly higher levels of eotaxin in the bronchoalveolar lavage (BAL) fluid of subjects with asthma than in that of normal subjects (25 +/- 3 versus 15 +/- 2 pg/ml, p < 0.05). BAL eotaxin levels increased after segmental allergen challenge in all six subjects with atopic asthma tested, with a mean increase from 22 +/- 4 to 53 +/- 10 pg/ml (p = 0.013). Segmental allergen challenge was associated with a significant increase in the percentage of BAL macrophages and eosinophils that were immunopositive for eotaxin. Eotaxin mRNA was detectable by northern analysis in BAL cells exclusively from allergen-challenged segments. Allergen- induced increases in eotaxin levels were strongly associated with increases in BAL eosinophil recovery (r(2) = 0.88, p = 0.0036). Segmental allergen challenge also increased eotaxin expression in airway epithelial and endothelial cells obtained by endobronchial biopsy. These findings demonstrate, for the first time, that the airways of subjects with allergic asthma respond to allergen by increasing eotaxin expression. The tissue loci of eotaxin expression, the levels of eotaxin recovered in BAL fluid, and the association of eotaxin levels with eosinophil mobilization suggest either that eotaxin plays a mechanistic role in allergen-induced airway eosinophilia or that it serves as a biomarker for the causal mechanisms.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11401892     DOI: 10.1164/ajrccm.163.7.9812044

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  33 in total

Review 1.  Cytokine expression in allergic inflammation: systematic review of in vivo challenge studies.

Authors:  Manuel A R Ferreira
Journal:  Mediators Inflamm       Date:  2003-10       Impact factor: 4.711

2.  Rhinovirus infection of allergen-sensitized and -challenged mice induces eotaxin release from functionally polarized macrophages.

Authors:  Deepti R Nagarkar; Emily R Bowman; Dina Schneider; Qiong Wang; Jee Shim; Ying Zhao; Marisa J Linn; Christina L McHenry; Babina Gosangi; J Kelley Bentley; Wan C Tsai; Umadevi S Sajjan; Nicholas W Lukacs; Marc B Hershenson
Journal:  J Immunol       Date:  2010-07-19       Impact factor: 5.422

3.  High- and low-dose allergen challenges in asthmatic patients using inhaled corticosteroids.

Authors:  Wha-Yong Lee; Thomas Southworth; Steven Booth; Dave Singh
Journal:  Br J Clin Pharmacol       Date:  2015-03       Impact factor: 4.335

Review 4.  Activation states of blood eosinophils in asthma.

Authors:  M W Johansson
Journal:  Clin Exp Allergy       Date:  2014-04       Impact factor: 5.018

5.  Decreased allergic lung inflammatory cell egression and increased susceptibility to asphyxiation in MMP2-deficiency.

Authors:  David B Corry; Kirtee Rishi; John Kanellis; Attila Kiss; Li-zhen Song Lz; Jie Xu; Lili Feng; Zena Werb; Farrah Kheradmand
Journal:  Nat Immunol       Date:  2002-03-11       Impact factor: 25.606

6.  Quantitative assessment of airway remodelling and response to allergen in asthma.

Authors:  David C Adams; Alyssa J Miller; Matthew B Applegate; Josalyn L Cho; Daniel L Hamilos; Alex Chee; Jasmin A Holz; Margit V Szabari; Lida P Hariri; R Scott Harris; Jason W Griffith; Andrew D Luster; Benjamin D Medoff; Melissa J Suter
Journal:  Respirology       Date:  2019-03-07       Impact factor: 6.424

7.  The leukotriene B4 lipid chemoattractant receptor BLT1 defines antigen-primed T cells in humans.

Authors:  Sabina A Islam; Seddon Y Thomas; Christoph Hess; Benjamin D Medoff; Terry K Means; Christian Brander; Craig M Lilly; Andrew M Tager; Andrew D Luster
Journal:  Blood       Date:  2005-09-22       Impact factor: 22.113

8.  RUNX transcription factors: association with pediatric asthma and modulated by maternal smoking.

Authors:  Kathleen J Haley; Jessica Lasky-Su; Sara E Manoli; Lacey A Smith; Aliakbar Shahsafaei; Scott T Weiss; Kelan Tantisira
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-07-29       Impact factor: 5.464

9.  Effects of a dual CCR3 and H1-antagonist on symptoms and eosinophilic inflammation in allergic rhinitis.

Authors:  Lennart Greiff; Cecilia Ahlström-Emanuelsson; Ash Bahl; Thomas Bengtsson; Kerstin Dahlström; Jonas Erjefält; Henrik Widegren; Morgan Andersson
Journal:  Respir Res       Date:  2010-02-09

10.  Airway lipoxin A4 generation and lipoxin A4 receptor expression are decreased in severe asthma.

Authors:  Anna Planagumà; Shamsah Kazani; Gautham Marigowda; Oliver Haworth; Thomas J Mariani; Elliot Israel; Eugene R Bleecker; Douglas Curran-Everett; Serpil C Erzurum; William J Calhoun; Mario Castro; Kian Fan Chung; Benjamin Gaston; Nizar N Jarjour; William W Busse; Sally E Wenzel; Bruce D Levy
Journal:  Am J Respir Crit Care Med       Date:  2008-06-26       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.